期刊文献+

三种酶免试剂盒和电化学发光试剂盒检测HCV抗体的比较 被引量:3

Comparison of HCV antibody detected by three kinds of ELISA kits and electrochemiluminescence kit
暂未订购
导出
摘要 目的比较三种酶免试剂盒和电化学发光试剂盒检测HCV抗体的灵敏度、特异性以及相关性。方法采用酶联免疫吸附试验和电化学发光法检测35例临床确诊丙型肝炎患者和45例健康体检者血清,统计学分析采用卡方检验和Kappa检验。结果中山生物、罗氏公司、上海科华、英科新创试剂盒的灵敏度分别为94.3%、100%、94.3%、100%,特异性分别为93.3%、93.3%、97.8%、93.3%。四家公司试剂盒之间检测阳性率差异没有统计学意义(P>0.05)。四家公司试剂间均有良好的一致性(Kappa值均大于等于0.8,P均小于0.01)。结论四家公司HCV抗体筛查试剂盒检测结果无显著差异。筛查阳性标本应做进一步确诊试验。 Objective To compare the sensitivity and specificity of HCV antibody detected by three kinds of ELISA kits and electrochemiluminescence kit and to analyze their correlation.Methods The serum samples of 35 patients suffering from viral hepatitis C and 45 health persons were detected by enzyme linked immnosorbent assay(ELISA) and electrochemiluminescence assay.The statistical analysis methods were Chi-square test and Kappa test.Results The sensitivities of Zhongshan,Roche,Kehua and Xinchuang were 94.3%,100%,94.3% and 100% respectively and their specificities were 93.3%,93.3%,97.8% and 93.3% respectively.The positive rates of four kits had no significant differences(P0.05) and there was good consistency among four kits(K≥0.8 and P0.01).Conclusion The results of four HCV antibody kits had no significant difference and the positive samples in screening tests should make a confirmatory test.
出处 《安徽医药》 CAS 2012年第8期1092-1094,共3页 Anhui Medical and Pharmaceutical Journal
基金 国家自然科学基金(No 30801088) 安徽省卫生厅临床医学应用技术项目(No 2008A022) 安徽省高校自然科研基金(No KJ2009B078)
关键词 HCV抗体 酶联免疫吸附试验 电化学发光法 HCV antibody enzyme linked immnosorbent assay electrochemiluminescence assay
  • 相关文献

参考文献8

  • 1范秀英,武德廉.干扰素治疗慢性肝炎的现状[J].安徽医药,1999,3(3):14-16. 被引量:3
  • 2Guo CH,Chen PC,Lin KP. Trace metal imbalance associated with oxidative stress and inflammatory status in anti-hepatitis C virus antibody positive subjects[J].Environmental Toxicology and Pharmacology,2012,(02):288-296.
  • 3Hermanstyne K,Bangsberg DR,Hennessey K. The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco[J].Journal of Public Health,2012.
  • 4Balogun TM,Akinsete I,Durosinmi MA. Risk factors and seroprevalence of hepatitis C virus antibody among blood donors in Lagos[J].Niger Postgrad Med J,2012,(01):36-39.
  • 5Lai JC,O'Leary JG,Trotter JF. Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors:A multicenter cohort study[J].Liver Transplantation,2012,(05):532-538.
  • 6徐少保,熊自忠,高人焘,沈强.丙型肝炎病毒基因型的研究进展[J].安徽医药,2009,13(8):869-871. 被引量:3
  • 7Park Y,Seok Y,Choi J. Performance evaluation of the Vitros anti-hepatitis C virus antibody assay for use in clinical laboratories[J].Clinical Biochemistry,2012,(1/2):175-177.
  • 8Jewett A,Smith BD,Garfein RS. Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR(Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego,CA[J].Journal of Clinical Virology,2012.

二级参考文献39

  • 1谢尧,赵辉,鸥蔚妮,闫杰,杜邵财,徐道振.不同感染途径慢性丙型肝炎患者HCV基因型分布的差异[J].中华实验和临床病毒学杂志,2004,18(3):247-250. 被引量:30
  • 2王阁.干扰素治疗各型病毒性肝炎的比较[J].国外医学(流行病学.传染病学分册),1994,21(5):209-212. 被引量:11
  • 3刘志英,魏红山,戴旺苏,张四平,刘顺爱,张剑平,宋淑静,董庆鸣,蒋为.北京地区丙型肝炎患者的丙型肝炎病毒基因分型[J].中华流行病学杂志,2005,26(2):148-149. 被引量:33
  • 4蔡怡珊,黄金宝,郑大利.中国部分地区丙型肝炎病毒核心区基因分型的研究[J].中国国境卫生检疫杂志,2006,29(3):139-142. 被引量:12
  • 5Alberti A, Benvegnu L. Management of hepatitis C [ J ]. Hepatol, 2003,38 ( Suppl 1 ) : 104 - 18.
  • 6Kang SM, Choi SH, Park CY, et al. Monoclonal antibod recognizing N-terminal epitope of hepatitis C virus non-Structural 5B inhibits viral RNA replication [ J ]. Viral Hepat ,2008,15 (4) :305 - 13.
  • 7Hino K,Yamaguchi Y,Fujiwara D,et al. Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic heatitis C:a prospective study[J]. J Viral Hepat,2000,7(1 ) :36 -42.
  • 8Simmonds P. Genetic diversity and evolution of hepatitis C virus 15 - years on[ J]. Gen Virol,2004,85 ( pt 11 ) :3173 - 88.
  • 9Nguyen MH, Keeffe EB. Chronic hepatitis C : genotypes 4 to 9 [ J ]. Clin Liver Dis ,2005,9 ( 3 ) :411 - 26.
  • 10Lu L, Nakano T, He Y, et al. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants [ J ]. J Med Virol, 2005,75 (4) :538 -49.

共引文献4

同被引文献61

  • 1曹娅丽,章友康.血液透析患者丙型肝炎病毒感染的特点及防治[J].中国血液净化,2012,11(8):409-412. 被引量:3
  • 2Penny Whiting,Anne WS Rutjes,Johannes B Reitsma,Patrick MM Bossuyt,Jos Kleijnen,刁骧(译),艾昌林(译),秦莉(审校),姚巡(审校).QUADAS的制定:用于系统评价中评价诊断性研究质量的工具[J].中国循证医学杂志,2007,7(4):296-306. 被引量:68
  • 3Penny F Whiting,Marie E Weswood,Anne WS Rutjes,Johannes B Reitsma,Patrick NM Bossuyt,Jos Kleijnen,马章淳,钱楠.QUADAS评价:一种用于诊断性研究的质量评价工具(修订版)[J].中国循证医学杂志,2007,7(7):531-536. 被引量:65
  • 4Miriam JA, Bruce LE, Harold SM, et al. Public health service interagency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. American Journal of Infection Control, 1991, 40(RR-4): 1-17.
  • 5Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology, 2009, 49: 1335-1374.
  • 6Alter HJ, Purcell RH, Shin JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med, 1989, 321: 1494-1500.
  • 7Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B Hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology, 1990, 12: 671-675.
  • 8Tong MJ, El-Farra NS, Reikes AR, et al. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med, 1995, 332: 1463-1466.
  • 9Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect, 2011, 17: 107-115.
  • 10Brown RS. Hepatitis C and liver transplantation. Nature, 2005, 436: 973-978.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部